* Helius Medical Technologies Inc is expected to show a fall in quarterly revenue when it reports results on August 12 for the period ending June 30 2024
* The Newtown Pennsylvania-based company is expected to report a 41.4% decrease in revenue to $150 thousand from $256 thousand a year ago, according to the estimate from one analyst, based on LSEG data.
* LSEG's mean analyst estimate for Helius Medical Technologies Inc is for a loss of 50 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Helius Medical Technologies Inc is $4.00, above its last closing price of $0.76.
This summary was machine generated August 9 at 22:32 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments